Elanco Animal Health Incorporated (NYSE: ELAN) Shares Have Been Down About -23.57% Year-To-Date Since The Beginning Of 2022 – Marketing Sentinel
Home  »  Science   »  Elanco Animal Health Incorporated (NYSE: ELAN) Sha...

Elanco Animal Health Incorporated (NYSE: ELAN) Shares Have Been Down About -23.57% Year-To-Date Since The Beginning Of 2022

During the recent session, Elanco Animal Health Incorporated (NYSE:ELAN)’s traded shares were 1.14 million, with the beta value of the company hitting 0.74. At the last check today, the stock’s price was $22.18, reflecting an intraday gain of 2.28% or $0.49. The 52-week high for the ELAN share is $37.49, that puts it down -69.03 from that peak though still a striking 7.53% gain since the share price plummeted to a 52-week low of $20.51. The company’s market capitalization is $10.44B, and the average intraday trading volume over the past 10 days was 6.41 million shares, and the average trade volume was 4.97 million shares over the past three months.

Elanco Animal Health Incorporated (ELAN) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.30. ELAN has a Sell rating from 0 analyst(s) out of 11 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.17.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Elanco Animal Health Incorporated (NYSE:ELAN) trade information

Elanco Animal Health Incorporated (ELAN) registered a 2.28% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.28% in intraday trading to $22.18 this Thursday, 05/12/22, hitting a weekly high. The stock’s 5-day price performance is -10.30%, and it has moved by -16.03% in 30 days. Based on these gigs, the overall price performance for the year is -36.11%. The short interest in Elanco Animal Health Incorporated (NYSE:ELAN) is 13.58 million shares and it means that shorts have 3.76 day(s) to cover.

The consensus price target of analysts on Wall Street is $35.29, which implies an increase of 37.15% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $30.00 and $40.00 respectively. As a result, ELAN is trading at a discount of -80.34% off the target high and -35.26% off the low.

Elanco Animal Health Incorporated (ELAN) estimates and forecasts

Statistics show that Elanco Animal Health Incorporated has outperformed its competitors in share price, compared to the industry in which it operates. Elanco Animal Health Incorporated (ELAN) shares have gone down -34.23% during the last six months, with a year-to-date growth rate more than the industry average at 11.43% against 3.00. In the rating firms’ projections, revenue will increase 45.20% compared to the previous financial year.

Revenue for the current quarter is expected to be $1.11 billion as predicted by 8 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to $1.25 billion by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $1.14 billion and $1.24 billion respectively. In this case, analysts expect current quarter sales to shrink by -2.90% and then jump by 0.80% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -48.40%. While earnings are projected to return 23.70% in 2022, the next five years will return 13.00% per annum.

ELAN Dividends

Elanco Animal Health Incorporated is due to release its next quarterly earnings between February 22 and February 28. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Elanco Animal Health Incorporated (NYSE:ELAN)’s Major holders

Elanco Animal Health Incorporated insiders own 4.23% of total outstanding shares while institutional holders control 103.25%, with the float percentage being 107.81%. Price (T.Rowe) Associates Inc is the largest shareholder of the company, while 647 institutions own stock in it. As of Sep 29, 2021, the company held over 46.97 million shares (or 9.93% of all shares), a total value of $1.5 billion in shares.

The next largest institutional holding, with 40.86 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 8.64% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $1.3 billion.

Also, the Mutual Funds coming in first place with the largest holdings of Elanco Animal Health Incorporated (ELAN) shares are Vanguard/Primecap Fund and Vanguard Specialized-Health Care Fund. Data provided on Sep 29, 2021 indicates that Vanguard/Primecap Fund owns about 13.94 million shares. This amounts to just over 2.95 percent of the company’s overall shares, with a $444.66 million market value. The same data shows that the other fund manager holds slightly less at 12.78 million, or about 2.70% of the stock, which is worth about $420.2 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts